Vise Technologies Inc. Takes $5.98 Million Position in HCA Healthcare, Inc. $HCA

Key Points

• Vise Technologies purchased a new $5.98 million stake in HCA Healthcare during the second quarter, acquiring 15,333 shares. Institutional investors and hedge funds collectively own 62.73% of HCA’s stock.
• HCA reported quarterly earnings of $7.59 per share and revenue of $20.23 billion, exceeding analyst estimates, while revenue increased 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, yielding 0.8% annually.
• Analysts maintain a consensus “Moderate Buy” rating with an average price target of $462.64, despite several recent target reductions. HCA shares recently opened at $406.33, below their 200-day moving average of $444.25.

Vise Technologies Inc. purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 15,333 shares of the company's stock, valued at approximately $5,978,000.

A number of other institutional investors have also recently modified their holdings of HCA. Sumitomo Life Insurance Co. increased its stake in shares of HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company's stock valued at $946,000 after purchasing an additional 20 shares in the last quarter. MJP Associates Inc. ADV increased its position in shares of HCA Healthcare by 2.9% in the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company's stock valued at $350,000 after buying an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC lifted its position in shares of HCA Healthcare by 7.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company's stock valued at $140,000 after buying an additional 21 shares in the last quarter. Anchyra Partners LLC increased its holdings in HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company's stock worth $278,000 after acquiring an additional 21 shares in the last quarter. Finally, Plato Investment Management Ltd lifted its holdings in HCA Healthcare by 0.6% during the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company's stock valued at $1,833,000 after purchasing an additional 22 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $406.33 on Friday. The business's 50 day moving average price is $396.32 and its 200 day moving average price is $444.25. The company has a market cap of $87.97 billion, a price-to-earnings ratio of 13.60, a PEG ratio of 1.41 and a beta of 1.10. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same quarter in the previous year, the firm earned $6.84 EPS. The company's quarterly revenue was up 8.7% compared to the same quarter last year. On average, analysts predict that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio is 10.45%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Argus decreased their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a "buy" rating on the stock in a research note on Monday, May 4th. Sanford C. Bernstein restated a "market perform" rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Leerink Partners dropped their price target on HCA Healthcare from $573.00 to $500.00 and set an "outperform" rating for the company in a research report on Monday, April 27th. Cantor Fitzgerald lowered their target price on shares of HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating on the stock in a research note on Tuesday, July 7th. Finally, TD Cowen reduced their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a "buy" rating for the company in a research report on Monday, June 22nd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of "Moderate Buy" and a consensus price target of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source